
2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003
Robison LS, Westfall AO, Mugavero MJ, Kempf MC, Cole SR, Allison JJ, Willig JH, Raper JL, Wilcox CM, Saag MS.
Short-term Discontinuation of HAART Regimens More Common in Vulnerable Patient Populations
AIDS Res Hum Retroviruses 2008;24:1347-1355
Willig JH, Abroms S, Westfall AO, Routman J, Adusumilli S, Varshney M, Allison J, Chatham A, Raper JL, Kaslow RA, Saag MS, Mugavero MJ.
Increased regimen durability in the era of once daily fixed-dose combination antiretroviral therapy
AIDS 2008;22:1951-60
Tan R, Westfall AO, Willig JH, Mugavero MJ, Saag MS, Kaslow RA, Kempf MC.
J Acquir Immune Defic Syndr 2008;47:553-58
Willig JH, Jackson DA, Westfall AO, Allison JJ, Chang PW, Raper JL, Saag MS, Mugavero MJ.
Clinical Inertia in the Management of LDL Abnormalities in an HIV Clinic
Clin Infect Dis 2008;46:1315-18
Kitahata MM, Rodriguez B, Haubrich R, Boswell S, Mathews WC, Lederman MM, Lober WB, Rompaey SE, Crane HM, Moore RD, Bertram M, Kahn JO, Saag MS.
Cohort profile: the Centers for AIDS Research Network of Integrated Clinical Systems.
Int J Epidemiol. 2008 Feb 8.
Kahn J, Des Jarlais CD, Dobkin L, Barrs SF and Greenblatt RM.
JAIDS 2008 47 Suppl 1:S5-9.
Jiang W, Lederman MM, Mohner RJ, Rodriguez B, Nedrich TM, Harding CV, Sieg SF.
J Virol 82 (16): 7837-45, 2008.
Sieg SF, Bazdar DA, Lederman MM.
S-phase entry leads to cell death in circulating T cells from HIV-infected persons.
J Leukoc Biol 83 (6): 1382-7, 2008.
Crane, HM, Grunfeld, C, Harrington, RD, Ciechanowski, PS, & MM Kitahata.
HIV Med. 2008 Oct;9(9):780-6.